This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Oppenheimer analyst Suraj Kalia initiated coverage on Abbott Laboratories ABT with an Outperform rating and announced a price target of $130. Abbott shares gained 0.6% to close at $113.36 on Monday. See how other analysts view this stock.
Wells Fargo analyst Eva Fortea Verdejo initiated coverage on Arcus Biosciences, Inc. RCUS with an Overweight rating and announced a price target of $29. Arcus Biosciences shares gained 3.9% to close at $17.30 on Monday. See how other analysts view this stock.
Susquehanna analyst Charles Minervino initiated coverage on Howmet Aerospace Inc. HWM with a Positive rating and announced a price target of $120. Howmet Aerospace shares gained 0.8% to close at $102.83 on Monday. See how other analysts view this stock.
Morgan Stanley analyst Judah Frommer initiated coverage on Bicara Therapeutics Inc. BCAX with an Overweight rating and announced a price target of $35. Bicara Therapeutics shares fell 2.8% to close at $24.45 on Monday. See how other analysts view this stock.
Hovde Group initiated coverage on First National Corporation FXNC with an Outperform rating and announced a price target of $22. First National shares gained 0.9% to close at $18.37 on Monday. See how other analysts view this stock.